0000000000542679

AUTHOR

G. Durand

showing 2 related works from this author

Additional mailing phase for FIT after a medical offer phase: The best way to improve compliance with colorectal cancer screening in France

2017

International audience; Background: Compliance with colorectal cancer screening is critical to its effectiveness. The organisation of the mass screening programme in France has recently been modified with no evaluation of the consequences.Aims: To evaluate the impact of the way the screening test is delivered on compliance.Patients and Methods: During the first six months of the screening campaign (Ille-Vilaine, Brittany), general practitioners were asked to propose a faecal immunochemical test (FIT), OC-Sensor, to individuals at average risk for colorectal cancer (n = 152,097). A subset of non-participants in the medical phase (n = 13,071) was randomly chosen to receive a reminder that inc…

MaleMedical consultationColorectal cancer[ SDV.CAN ] Life Sciences [q-bio]/Cancer0302 clinical medicineMass ScreeningEarly Detection of Cancermedia_commonGastroenterology[ SDV.SPEE ] Life Sciences [q-bio]/Santé publique et épidémiologieMiddle Aged3. Good healthTest (assessment)Colorectal cancer screeningOccult Blood030220 oncology & carcinogenesisScreening[ SDV.MHEP.HEG ] Life Sciences [q-bio]/Human health and pathology/Hépatology and GastroenterologyFemale030211 gastroenterology & hepatologyFranceColorectal NeoplasmsCompliancemedicine.medical_specialtyReminder Systemseducation[SDV.CAN]Life Sciences [q-bio]/CancerCompliance (psychology)03 medical and health sciences[SDV.CAN] Life Sciences [q-bio]/CancermedicineHumansmedia_common.cataloged_instancePostal ServiceEuropean unionUptake rateMass screeningAgedGynecologyHepatologybusiness.industry[SDV.MHEP.HEG]Life Sciences [q-bio]/Human health and pathology/Hépatology and GastroenterologyImmunochemical testmedicine.diseaseColorectal cancer[SDV.MHEP.HEG] Life Sciences [q-bio]/Human health and pathology/Hépatology and Gastroenterology[SDV.SPEE] Life Sciences [q-bio]/Santé publique et épidémiologieFamily medicinePatient Compliance[SDV.SPEE]Life Sciences [q-bio]/Santé publique et épidémiologiebusinessDigestive and Liver Disease
researchProduct

Positivity rates and performances of immunochemical faecal occult blood tests at different cut-off levels within a colorectal cancer screening progra…

2012

Abstract Background Immunochemical faecal occult blood tests have greater sensitivity for colorectal cancer screening than guaiac-based tests; however the number of positive tests required is still under discussion. Methods A direct comparison of Hemoccult II with two immunochemical quantitative tests (OC-Sensor and FOB-Gold) using a 2-sample strategy was performed in over 30,000 patients undergoing colorectal cancer screening in France. Results Positivity ratio between immunochemical tests and Hemoccult II varied between 2.2 (OC-Sensor) and 2.4 (FOB-Gold) for the lowest cut-off value and 1.5–1.4 for the highest cut-off value. The positive predictive value for colorectal cancer was similar …

Gynecologymedicine.medical_specialtyHepatologybusiness.industryColorectal cancerGastroenterologyFaecal occult bloodmedicine.diseasePredictive valueGastroenterologyColorectal cancer screeningPredictive value of testsInternal medicineMedicineTest interpretationSampling (medicine)businessMass screeningDigestive and Liver Disease
researchProduct